Oxford Biomedica’s Post

Check out our latest research paper in Biotechnology and Bioengineering, in collaboration with University College London (UCL). A major and unaddressed process inefficiency which compromises the productivity of lentiviral vector manufacturing processes, and is likely widespread throughout the industry, is the unintended auto-transduction of viral vector producing cells by newly synthesised vector particles. Our team at OXB have characterised and quantified the impact of auto-transduction on lentiviral vector production, and developed an effective, economical, and scalable strategy to inhibit this phenomenon, thereby enhancing process performance. #CDMO #ViralVectors #AdvancedTherapies #Manufacturing #Innovation #Research #LentiviralVectors

To view or add a comment, sign in

Explore topics